Phase 1 Albumin Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Time Restricted Eating in Patients With Microalbuminuria
Type 2 Diabetes Mellitus (T2DM)Time Restricted EatingMicroalbuminuria
University of California, San Diego25 enrolled1 locationNCT06884059
Recruiting
Phase 1Phase 2
Chemoradiotherapy in Unresectable Esophageal Cancer
Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences105 enrolled5 locationsNCT04278287
Not Yet Recruiting
Phase 1
A Phase 1, Partially Blinded, Placebo-Controlled, Pharmacokinetic Study of Intravenously Administered BMS-943539-01-001 in Healthy Male Volunteers
Pharmacokinetics of Intravenously Administered BMS-943539 in Healthy Male Volunteers.
BMS-943539 is an Adnectin (protein) which is specifically engineered to bind to Human Serum Albumin (HSA).
Bristol-Myers Squibb Australia37 enrolled1 locationACTRN12610001043022